▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
_ 8.5390625
point 8.4765625
▁issue 7.9296875
▁among 8.0234375
▁at 6.91796875
▁least 1.4658203125
▁ 2.990234375
8 3.357421875
% 4.12109375
▁of 2.025390625
▁the 1.6005859375
▁residents 9.1484375
▁of 2.779296875
▁progress 9.0546875
ive 1.083984375
▁countries 8.0390625
. 2.5546875
▁The 2.66796875
▁introduction 7.265625
▁of 0.345703125
▁the 1.603515625
▁study 6.50390625
▁describes 8.0703125
▁the 0.89599609375
▁apparent 9.296875
▁link 6.7109375
▁between 0.5478515625
▁pain 6.26171875
▁and 0.861328125
▁dem 8.296875
oral 3.396484375
ization 0.2178955078125
. 1.57421875
▁Chron 5.8359375
ic 0.034576416015625
▁pain 0.35693359375
▁is 1.33203125
▁always 6.25
▁accompanied 2.62890625
▁by 0.037933349609375
▁negative 4.90625
▁emot 1.490234375
ional 1.2802734375
▁experiences 2.96875
▁and 2.158203125
▁blocks 10.9140625
▁a 4.25
▁person 1.56640625
’ 24.484375
s 2.6953125
▁ability 1.9775390625
▁to 0.041015625
▁receive 6.3125
▁joy 5.1015625
▁and 1.3896484375
▁satisfaction 3.064453125
▁from 1.25
▁life 1.046875
. 0.330810546875
▁The 1.9892578125
▁research 4.07421875
▁investig 5.3671875
ates 0.45654296875
▁the 0.464599609375
▁development 5.734375
▁of 0.172119140625
▁de 4.03125
pression 0.2176513671875
▁and 1.294921875
▁anx 2.3203125
iety 0.004596710205078125
▁among 2.185546875
▁patients 2.296875
▁receiving 4.484375
▁ph 6.57421875
arma 1.7265625
ce 0.010711669921875
ut 0.00032448768615722656
ical 0.01076507568359375
▁op 5.5859375
io 0.2396240234375
ids 0.7099609375
▁and 2.365234375
▁medical 6.328125
▁mar 1.7919921875
iju 0.04290771484375
ana 0.00017464160919189453
▁( 4.40625
MM 0.787109375
) 3.310546875
▁as 2.888671875
▁severe 9.8203125
▁pain 1.490234375
kill 2.923828125
ers 0.002559661865234375
. 0.53564453125
▁It 3.328125
▁comp 5.2265625
ares 0.051605224609375
▁the 0.60546875
▁effic 6.2109375
acy 0.00711822509765625
▁of 0.26318359375
▁pres 5.1640625
cri 1.8427734375
ptions 0.62451171875
▁and 2.27734375
▁exam 5.9609375
ines 0.0111541748046875
▁the 0.435302734375
▁possibility 3.6171875
▁of 0.111328125
▁post 7.1328125
- 0.71630859375
tre 2.611328125
at 0.021575927734375
ment 0.007793426513671875
▁de 1.833984375
pression 0.0931396484375
. 1.7509765625
<0x0A> 2.369140625
There 4.83984375
▁const 13.3203125
itute 0.14111328125
▁currently 6.90234375
▁a 2.765625
▁severe 6.859375
▁lack 3.06640625
▁of 0.028350830078125
▁information 2.361328125
▁about 1.439453125
▁the 0.419677734375
▁effects 2.994140625
▁of 0.08245849609375
▁op 1.9775390625
i 3.671875
ates 0.1405029296875
. 3.7265625
▁They 4.74609375
▁manage 8.6953125
▁pain 4.08984375
▁successfully 5.578125
, 1.0341796875
▁but 0.400634765625
▁the 2.6953125
▁past 9.5859375
▁few 2.462890625
▁dec 0.93603515625
ades 0.00012385845184326172
▁indicated 9.15625
▁the 2.033203125
▁growing 4.7109375
▁concern 3.654296875
▁regarding 2.794921875
▁op 3.83203125
iate 0.67333984375
▁ab 1.595703125
use 0.0103607177734375
▁in 3.3515625
▁forms 10.1953125
▁of 0.402587890625
▁over 3.31640625
d 0.282470703125
ose 0.2080078125
▁and 0.7099609375
▁add 1.1611328125
iction 0.03369140625
. 0.257568359375
▁A 3.990234375
▁more 5.6640625
▁manage 9.2734375
able 0.0048065185546875
▁and 2.244140625
▁sa 2.361328125
fer 0.00013363361358642578
▁alternative 1.861328125
▁might 6.18359375
▁be 0.193115234375
▁medical 2.9453125
▁mar 0.2144775390625
iju 0.004924774169921875
ana 0.0006585121154785156
. 1.6416015625
▁However 2.966796875
, 0.01174163818359375
▁the 1.568359375
▁legal 4.2109375
▁status 1.287109375
▁and 2.833984375
▁novel 9.1640625
ty 0.705078125
▁of 0.2032470703125
▁this 1.5673828125
▁drug 2.125
▁do 4.9609375
▁not 0.0823974609375
▁allow 1.0732421875
▁finding 8.7421875
▁a 2.357421875
▁large 4.29296875
▁number 1.400390625
▁of 0.0039215087890625
▁studies 1.4228515625
▁on 1.556640625
▁its 0.974609375
▁effect 2.14453125
iveness 0.40576171875
. 1.0673828125
▁Specifically 8.046875
, 0.128173828125
▁it 2.68359375
▁concerns 4.93359375
▁the 0.615234375
▁ar 9.3828125
oused 5.3515625
▁condition 6.02734375
▁of 0.271728515625
▁patients 1.546875
▁experien 5.42578125
cing 7.784366607666016e-05
▁chron 1.380859375
ic 0.002719879150390625
▁pain 0.1337890625
. 1.0478515625
▁This 3.3203125
▁research 3.060546875
▁paper 6.14453125
▁a 2.267578125
ims 0.0005421638488769531
▁to 0.1483154296875
▁analyze 2.984375
▁levels 9.890625
▁of 0.040679931640625
▁de 0.70556640625
pression 0.041168212890625
▁and 0.28515625
▁anx 0.054656982421875
iety 0.001373291015625
▁among 0.82861328125
▁people 3.259765625
▁receiving 1.044921875
▁ther 7.8671875
apy 0.318115234375
▁by 4.96484375
▁comparing 8.3515625
▁the 0.9658203125
▁effects 2.181640625
▁of 0.03265380859375
▁ph 2.509765625
arma 0.046234130859375
ce 0.00157928466796875
ut 6.842613220214844e-05
ical 0.004261016845703125
▁op 0.319091796875
io 0.172607421875
ids 0.05523681640625
▁and 0.281982421875
▁MM 1.5869140625
. 1.14453125
<0x0A> 1.1904296875
The 1.3642578125
▁study 2.240234375
▁was 2.2421875
▁conducted 0.833984375
▁in 1.5595703125
▁the 1.3486328125
▁form 2.287109375
▁of 0.00838470458984375
▁collection 9.984375
▁and 1.75390625
▁analysis 0.736328125
▁of 0.044403076171875
▁statistical 4.12890625
▁data 0.1358642578125
. 0.9921875
▁Part 5.05859375
icip 0.0797119140625
ants 0.05377197265625
▁were 0.79443359375
▁rec 3.490234375
ru 0.00135040283203125
ited 5.030632019042969e-05
▁for 3.986328125
▁six 7.54296875
▁months 0.51025390625
▁at 3.736328125
▁two 2.59375
▁major 5.4296875
▁pain 3.44140625
▁relief 5.3515625
▁cent 1.4453125
ers 0.08026123046875
▁in 0.75146484375
▁Israel 4.41796875
. 0.478515625
▁The 1.1650390625
▁research 2.265625
ers 1.6328125
▁used 2.744140625
▁The 8.2421875
▁De 4.2890625
pression 0.01427459716796875
▁Module 9.8125
▁of 1.0087890625
▁the 0.320556640625
▁Pat 2.349609375
ient 0.00876617431640625
▁Health 0.08758544921875
▁Question 0.015533447265625
naire 0.019287109375
▁and 3.40625
▁the 0.7177734375
▁General 1.7060546875
ized 0.68017578125
▁An 0.0181884765625
x 0.00017142295837402344
iety 0.0027675628662109375
▁Dis 0.58251953125
order 0.03668212890625
▁Sc 1.2119140625
ale 0.07781982421875
▁to 1.8310546875
▁interview 7.00390625
▁participants 2.099609375
, 3.52734375
▁evaluate 5.70703125
▁their 0.76904296875
▁answers 6.41796875
, 0.9267578125
▁and 0.160888671875
▁conduct 4.42578125
▁the 2.2421875
▁study 2.306640625
. 0.2447509765625
▁To 5.1796875
▁specifically 9.9296875
▁evaluate 2.669921875
▁and 4.31640625
▁compare 1.0341796875
▁the 0.31591796875
▁prob 10.7109375
abilities 0.18505859375
▁of 0.1341552734375
▁de 0.8876953125
pression 0.041046142578125
▁or 4.54296875
▁anx 0.043182373046875
iety 0.0003573894500732422
▁among 1.67578125
▁the 2.25
▁diverse 8.7890625
▁groups 1.5576171875
, 1.4892578125
▁the 1.0185546875
▁study 2.654296875
▁used 1.6787109375
▁multiple 4.80078125
▁log 2.890625
istic 0.037445068359375
▁regression 0.10211181640625
▁analysis 0.6513671875
▁and 2.56640625
▁chose 8.7578125
▁medical 7.42578125
▁mar 0.399658203125
iju 0.0018377304077148438
ana 0.0002505779266357422
▁as 0.80859375
▁the 1.1435546875
▁control 2.84765625
▁group 0.5966796875
. 0.3173828125
<0x0A> 0.74267578125
This 3.626953125
▁type 5.87890625
▁of 0.00823211669921875
▁study 1.8671875
▁is 1.31640625
▁the 3.43359375
▁most 1.8994140625
▁reve 9.1328125
aling 0.0008330345153808594
▁and 1.07421875
▁inclus 6.5703125
ive 0.0030841827392578125
, 2.2890625
▁as 1.9345703125
▁it 0.360107421875
▁contains 4.8828125
▁direct 6.3359375
▁responses 5.15625
▁from 0.87548828125
▁a 3.84375
▁large 0.98876953125
▁number 0.429931640625
▁of 0.0037631988525390625
▁participants 1.5009765625
. 0.68408203125
▁All 4.68359375
▁tools 9.1015625
▁in 4.47265625
▁the 0.66357421875
▁form 3.328125
▁of 0.038360595703125
▁question 1.74609375
na 0.038543701171875
ires 0.00010919570922851562
▁and 2.099609375
▁scales 3.091796875
▁have 3.64453125
▁already 4.53515625
▁been 0.1873779296875
▁used 2.005859375
▁and 2.1171875
▁proved 4.234375
▁their 1.7392578125
▁effic 3.86328125
acy 9.882450103759766e-05
▁for 3.564453125
▁collect 4.4609375
ing 0.01715087890625
▁analyt 8.1640625
ical 0.2386474609375
▁data 0.28857421875
. 0.47216796875
▁It 3.564453125
▁helps 4.8359375
▁to 0.8994140625
▁system 7.22265625
at 1.1650390625
ize 0.006744384765625
▁and 1.576171875
▁class 4.015625
ify 0.0026187896728515625
▁clear 11.109375
- 3.732421875
cut 0.0369873046875
▁kinds 8.8984375
▁of 0.07696533203125
▁information 3.5234375
▁for 4.0234375
▁subsequent 4.296875
▁un 7.90625
comp 4.6640625
licated 0.0506591796875
▁services 11.2578125
. 0.70068359375
▁Thus 4.2578125
, 0.03070068359375
▁research 4.59375
ers 0.62109375
▁can 1.54296875
▁compare 4.109375
▁the 0.9208984375
▁effects 2.984375
▁of 0.107666015625
▁medic 4.4375
ations 0.97802734375
▁on 1.9248046875
▁patients 1.927734375
▁of 4.51171875
▁diverse 4.3671875
▁age 2.701171875
▁groups 0.67333984375
, 0.97216796875
▁background 5.12109375
s 0.2386474609375
, 0.08795166015625
▁physical 5.3125
▁conditions 1.4775390625
, 0.100830078125
▁emot 5.93359375
ional 0.06756591796875
▁states 1.2958984375
, 0.11175537109375
▁and 0.46728515625
▁so 3.220703125
▁on 0.3232421875
. 0.10382080078125
<0x0A> 0.6708984375
The 1.1220703125
▁analysis 4.4296875
▁of 0.56005859375
▁whatever 15.5859375
▁human 7.82421875
▁reaction 5.33984375
▁has 3.943359375
▁a 2.3046875
▁high 4.07421875
▁potential 3.62109375
▁of 1.546875
▁subject 7.33203125
iveness 3.85546875
▁and 1.1396484375
▁bias 3.263671875
, 1.71875
▁especially 2.78125
▁regarding 4.32421875
▁people 4.38671875
▁in 4.05859375
▁severe 4.49609375
▁pain 0.3095703125
▁and 2.55078125
▁un 5.2265625
stable 2.111328125
▁emot 1.158203125
ional 0.2017822265625
▁condition 3.283203125
. 0.10272216796875
▁Perhaps 8.7109375
▁some 5.0625
▁patients 2.439453125
▁tend 5.38671875
▁to 0.0242919921875
▁ex 2.57421875
agger 0.0019512176513671875
ate 0.005657196044921875
▁their 0.79443359375
▁de 5.0
press 1.3701171875
ive 0.302978515625
▁state 3.04296875
▁or 1.8984375
▁vice 7.34765625
▁vers 0.0230255126953125
a 6.139278411865234e-05
, 1.0849609375
▁de 7.40234375
- 4.859375
emph 1.1328125
as 0.006256103515625
ize 0.205078125
▁serious 6.62109375
▁difficulties 6.0859375
. 0.94189453125
▁Because 6.2109375
▁the 2.248046875
▁survey 6.17578125
▁responses 6.796875
▁were 1.8173828125
▁thoroughly 7.91015625
▁anonymous 4.90234375
, 0.448974609375
▁the 1.47265625
▁research 1.65234375
ers 0.321533203125
▁were 1.5185546875
▁unable 2.728515625
▁to 0.00455474853515625
▁carefully 8.7578125
▁analyze 1.677734375
▁each 4.2890625
▁patient 2.380859375
’ 27.15625
s 0.54833984375
▁reaction 3.57421875
▁and 2.37109375
▁compare 3.46484375
▁it 0.84228515625
▁to 1.3662109375
▁the 0.78173828125
▁actual 5.48828125
▁states 7.17578125
▁of 0.66015625
▁condition 6.984375
. 0.3994140625
▁More 6.80078125
▁accurate 3.953125
▁answers 4.6015625
▁could 2.50390625
▁be 0.7783203125
▁obtained 1.0302734375
▁by 1.3994140625
▁professional 7.43359375
▁psych 2.244140625
olog 0.33447265625
ists 0.0011835098266601562
▁via 7.7890625
▁personal 3.9375
▁communication 4.734375
▁and 1.875
▁behavior 7.23828125
al 0.35009765625
▁analysis 2.373046875
. 0.2427978515625
▁However 3.169921875
, 0.0038928985595703125
▁this 2.0
▁method 2.884765625
▁of 2.302734375
▁research 2.12109375
▁is 1.015625
▁way 7.8828125
▁more 1.701171875
▁resource 6.51171875
- 0.548828125
int 0.65673828125
ensive 0.0084075927734375
▁and 0.654296875
▁energy 8.53125
- 0.098876953125
consum 0.299560546875
ing 0.001678466796875
. 0.6083984375
<0x0A> 0.57421875
Part 5.61328125
icip 0.09381103515625
ants 0.11761474609375
▁were 0.974609375
▁rec 1.4873046875
ru 0.0010919570922851562
ited 6.604194641113281e-05
▁for 1.1103515625
▁six 1.0419921875
▁months 0.0198974609375
▁at 0.429931640625
▁two 0.10028076171875
▁major 0.291748046875
▁pain 0.0299835205078125
▁relief 0.0253143310546875
▁cent 0.034332275390625
ers 0.003963470458984375
▁in 0.059478759765625
▁Israel 0.0297088623046875
. 0.154052734375
▁All 3.4921875
▁patients 1.6005859375
▁experienced 5.97265625
▁chron 1.962890625
ic 0.002777099609375
▁pain 0.09234619140625
▁for 3.595703125
▁at 0.748046875
▁least 0.0010290145874023438
▁ 1.05078125
3 1.41015625
▁months 0.21630859375
. 0.998046875
▁The 1.474609375
▁study 1.9912109375
▁included 2.18359375
▁ 1.0791015625
8 2.84375
9 2.794921875
0 3.564453125
▁participants 1.5791015625
, 1.240234375
▁of 1.7333984375
▁which 0.4765625
▁ 0.1536865234375
4 1.6396484375
7 2.466796875
4 2.767578125
▁( 2.216796875
5 0.0948486328125
9 11.125
%) 1.0380859375
▁were 0.4794921875
▁treated 4.6484375
▁sole 6.67578125
ly 0.00019991397857666016
▁with 0.493408203125
▁op 0.79443359375
io 0.43310546875
ids 0.2059326171875
, 1.107421875
▁ 0.59619140625
3 1.05859375
2 2.1015625
9 2.529296875
▁( 0.04388427734375
4 1.22265625
1 1.2763671875
%) 0.1363525390625
▁were 1.294921875
▁treated 0.50244140625
▁with 0.208984375
▁MM 0.88818359375
, 0.2578125
▁and 0.1641845703125
▁ 0.1368408203125
7 3.16796875
7 2.41796875
▁( 0.1690673828125
8 3.794921875
. 1.181640625
6 2.97265625
%) 0.053955078125
▁acquired 9.5703125
▁both 1.18359375
▁( 6.91796875
Fe 9.8828125
ing 2.494140625
old 0.020294189453125
▁et 1.40625
▁al 0.0162811279296875
., 0.320556640625
▁ 0.0109100341796875
2 0.147705078125
0 0.0004134178161621094
1 0.39453125
7 2.142578125
). 0.12396240234375
▁The 1.326171875
▁remaining 7.23828125
▁ten 8.0546875
▁participants 1.48828125
▁who 5.58203125
▁did 1.5048828125
▁not 0.007160186767578125
▁receive 1.8935546875
▁ph 3.115234375
arma 0.058258056640625
ce 0.0016231536865234375
ut 1.823902130126953e-05
ical 0.0039825439453125
▁op 1.3134765625
io 0.0787353515625
ids 0.0221405029296875
▁and 1.6494140625
▁medical 2.46484375
▁mar 0.043701171875
iju 0.00437164306640625
ana 6.246566772460938e-05
▁were 1.2421875
▁with 5.9453125
dra 0.1380615234375
wn 0.00010955333709716797
▁from 0.26806640625
▁the 0.1116943359375
▁analysis 4.515625
▁in 4.76953125
▁the 1.2060546875
▁research 4.25390625
. 0.73974609375
▁Therefore 4.875
, 0.01007843017578125
▁it 3.71484375
▁is 0.98779296875
▁not 2.703125
▁possible 0.69482421875
▁to 0.0244598388671875
▁compreh 6.56640625
ens 0.07879638671875
ively 0.0106201171875
▁compare 1.8984375
▁patients 4.69140625
▁taking 4.328125
▁medic 3.8203125
ations 0.47119140625
▁with 0.93994140625
▁those 1.185546875
▁who 1.1708984375
▁do 1.7001953125
▁not 0.0089569091796875
. 0.78857421875
<0x0A> 0.60498046875
The 1.130859375
▁study 1.7255859375
▁conducted 4.765625
▁a 2.138671875
▁correlation 6.015625
▁type 7.125
▁of 0.42626953125
▁inqu 7.578125
iry 0.002964019775390625
▁with 3.091796875
▁variable 8.1484375
▁measures 4.9140625
. 1.552734375
▁It 2.17578125
▁measure 10.3203125
▁the 0.908203125
▁inter 6.30859375
dep 3.32421875
end 0.0011186599731445312
ence 0.0092315673828125
▁of 0.58984375
▁various 3.908203125
▁factors 1.6904296875
▁that 2.873046875
▁affected 4.77734375
▁the 0.58447265625
▁physical 7.1484375
▁and 1.0380859375
▁emot 0.75537109375
ional 0.000553131103515625
▁condition 1.5048828125
▁of 0.1656494140625
▁patients 0.7275390625
▁experien 5.140625
cing 2.8133392333984375e-05
▁chron 0.72314453125
ic 0.0005803108215332031
▁pain 0.0298614501953125
. 0.23193359375
▁For 3.740234375
▁example 1.0400390625
, 0.0187530517578125
▁the 1.2568359375
▁survey 5.171875
▁showed 3.791015625
▁that 0.421142578125
▁the 1.6826171875
▁ratio 6.890625
▁of 0.1015625
▁female 3.998046875
▁patients 0.66259765625
▁was 1.6806640625
▁remark 9.421875
ably 0.0005574226379394531
▁higher 0.53857421875
▁in 2.697265625
▁the 0.96435546875
▁op 4.546875
i 3.9140625
ates 0.09228515625
▁group 0.29541015625
▁compared 2.798828125
▁to 0.1446533203125
▁the 0.49658203125
▁MM 0.53466796875
▁group 0.29052734375
. 0.486083984375
▁In 2.970703125
▁turn 4.19921875
, 0.00466156005859375
▁people 6.0234375
▁on 5.421875
▁op 1.3671875
i 0.42822265625
ates 0.003520965576171875
▁were 1.126953125
▁more 1.04296875
▁likely 0.436767578125
▁to 0.07183837890625
▁report 3.201171875
▁major 6.078125
▁de 0.427734375
press 1.20703125
ive 0.00440216064453125
▁dis 0.50048828125
orders 1.3720703125
. 1.7861328125
<0x0A> 2.5546875
The 1.1416015625
▁question 5.45703125
na 1.48046875
ires 8.535385131835938e-05
▁used 2.185546875
▁different 7.7265625
▁variable 8.546875
▁measures 0.7744140625
▁to 1.376953125
▁collect 2.392578125
▁information 1.8466796875
. 1.65625
▁For 1.982421875
▁example 0.2261962890625
, 0.0102081298828125
▁it 3.88671875
▁included 2.720703125
▁compreh 8.7578125
ensive 0.034912109375
▁so 6.90234375
cio 0.02349853515625
- 0.38623046875
dem 0.09521484375
ographic 0.040557861328125
▁data 1.029296875
: 4.76171875
▁gender 1.6171875
, 0.09912109375
▁age 0.2144775390625
, 0.0943603515625
▁country 4.33984375
, 1.4990234375
▁type 4.37109375
▁of 0.057342529296875
▁residence 3.771484375
▁( 3.353515625
urban 2.060546875
/ 2.869140625
r 0.0626220703125
ural 0.0005145072937011719
), 0.2294921875
▁years 5.9453125
▁of 0.1685791015625
▁education 0.681640625
, 0.1480712890625
▁and 1.8681640625
▁employ 3.654296875
ment 0.00441741943359375
▁status 0.468017578125
. 0.1829833984375
▁Pat 4.046875
ients 0.10272216796875
▁were 1.21875
▁also 1.0205078125
▁asked 0.603515625
▁about 1.171875
▁their 0.6240234375
▁medical 2.76953125
▁history 0.43359375
▁over 8.671875
▁the 0.1781005859375
▁years 3.8828125
▁and 1.8671875
▁the 1.8271484375
▁current 3.3984375
▁presence 5.73828125
▁of 0.05487060546875
▁any 2.6484375
▁severe 4.6953125
▁dise 1.447265625
ases 9.274482727050781e-05
▁such 4.22265625
▁as 0.004974365234375
▁heart 2.3828125
▁failure 2.087890625
, 0.1873779296875
▁di 1.8544921875
ab 0.00191497802734375
etes 0.004657745361328125
, 0.1307373046875
▁ar 3.74609375
th 0.17138671875
rit 0.038482666015625
is 0.01428985595703125
, 0.04315185546875
▁and 1.58203125
▁so 0.74951171875
▁on 0.03363037109375
. 0.048126220703125
▁The 1.9189453125
▁third 7.15625
▁measure 3.90234375
▁of 2.029296875
▁the 1.0048828125
▁question 2.619140625
naire 0.1943359375
▁was 1.0859375
▁indicated 9.78125
▁by 0.56298828125
▁information 6.33984375
▁on 1.576171875
▁any 5.5390625
▁twelve 13.640625
- 1.236328125
month 0.356689453125
▁and 5.8125
▁lifetime 3.025390625
▁drug 4.66015625
▁and 3.486328125
▁alco 0.08062744140625
hol 9.179115295410156e-05
▁consumption 2.6640625
. 0.47216796875
▁In 3.46875
▁addition 0.8134765625
, 0.123779296875
▁the 1.158203125
▁record 7.6796875
▁included 1.8203125
▁a 2.509765625
▁pain 6.3515625
▁measurement 4.2734375
▁scale 1.1083984375
▁from 3.69921875
▁ 0.464599609375
0 0.436767578125
▁to 0.4111328125
▁ 0.007236480712890625
1 0.0950927734375
0 0.0816650390625
▁to 4.63671875
▁evaluate 1.8623046875
▁dis 5.9140625
com 0.20361328125
fort 0.0018930435180664062
▁feelings 7.45703125
▁during 3.408203125
▁the 0.86279296875
▁last 1.4404296875
▁month 1.626953125
. 0.28369140625
<0x0A> 1.076171875
Am 6.87109375
ong 0.01068878173828125
▁all 2.306640625
▁participants 2.033203125
▁in 3.525390625
▁the 0.1719970703125
▁study 0.39501953125
, 0.06707763671875
▁ 0.646484375
4 1.763671875
2 2.728515625
. 1.888671875
2 2.294921875
% 0.1378173828125
▁suffered 4.78125
▁from 0.150634765625
▁de 1.8251953125
pression 0.1556396484375
, 1.0517578125
▁and 1.72265625
▁ 0.153564453125
3 1.7080078125
7 2.236328125
% 2.71484375
▁experienced 2.390625
▁excess 7.67578125
ive 0.09625244140625
▁anx 0.258544921875
iety 0.0015115737915039062
. 0.339599609375
▁The 1.4326171875
▁pl 11.015625
ur 1.0283203125
ality 0.0001951456069946289
▁of 0.1954345703125
▁de 3.455078125
press 1.296875
ive 0.026458740234375
▁dis 1.828125
orders 0.06298828125
▁among 3.7734375
▁patients 1.169921875
▁in 3.5859375
▁the 0.364013671875
▁op 1.33203125
i 0.92919921875
ates 0.004611968994140625
, 7.06640625
▁medical 3.029296875
▁mar 0.020416259765625
iju 0.0062713623046875
ana 3.230571746826172e-05
, 0.122802734375
▁and 0.0660400390625
▁mixed 6.03125
▁OP 8.78125
MM 5.69140625
▁group 1.9873046875
▁number 7.84375
ed 0.040374755859375
▁ 0.09228515625
5 2.154296875
7 2.47265625
. 0.251708984375
1 2.34765625
%, 0.298095703125
▁ 0.00885009765625
2 2.958984375
2 2.4140625
. 0.10797119140625
3 2.240234375
%, 0.1312255859375
▁and 0.035369873046875
▁ 0.0031185150146484375
5 3.103515625
1 2.572265625
. 0.17431640625
4 2.134765625
%, 0.407470703125
▁respectively 0.012451171875
. 0.28173828125
▁The 1.455078125
▁pl 4.44921875
ur 0.0219879150390625
ality 3.3974647521972656e-05
▁of 0.0406494140625
▁anx 0.888671875
iety 0.01088714599609375
▁contained 10.9140625
▁ 0.51904296875
4 1.56640625
8 2.373046875
. 0.06402587890625
4 2.30859375
% 0.56689453125
▁among 1.400390625
▁OP 6.4453125
▁patients 9.3359375
, 0.285400390625
▁ 0.09417724609375
2 1.470703125
1 2.40625
. 0.1319580078125
5 2.455078125
% 0.0128936767578125
▁among 0.4404296875
▁MM 0.36572265625
▁patients 0.279052734375
, 0.0137176513671875
▁and 0.0156402587890625
▁ 0.0343017578125
3 1.22265625
8 2.6484375
. 0.158447265625
7 2.2890625
% 0.01415252685546875
▁among 0.229248046875
▁OP 3.90234375
MM 0.2025146484375
▁participants 3.685546875
. 0.226318359375
▁Pat 5.73046875
ients 0.02337646484375
▁who 2.466796875
▁took 2.861328125
▁strong 8.125
▁op 1.3134765625
i 1.4111328125
ates 0.0034618377685546875
▁were 1.7919921875
▁t 8.734375
ended 1.2724609375
▁to 0.01459503173828125
▁place 10.328125
▁their 3.568359375
▁pain 2.595703125
▁on 3.40625
▁a 0.94189453125
▁scale 2.33203125
▁of 0.6181640625
▁ 0.36865234375
9 2.75390625
▁to 1.380859375
▁ 0.0169677734375
1 0.02276611328125
0 0.0908203125
▁( 2.572265625
Fe 1.626953125
ing 0.00736236572265625
old 0.0004105567932128906
▁et 0.031768798828125
▁al 0.000823974609375
., 0.00675201416015625
▁ 0.0016431808471679688
2 0.0005340576171875
0 3.159046173095703e-05
1 0.0017604827880859375
7 0.012969970703125
). 0.046173095703125
▁They 4.7421875
▁were 1.3603515625
▁also 1.4833984375
▁an 8.6640625
gu 4.453125
ished 0.037261962890625
▁em 8.6015625
otion 0.01125335693359375
ally 0.0044708251953125
▁and 1.0888671875
▁react 6.91796875
▁rad 12.2578125
ically 0.004180908203125
▁neg 5.86328125
atively 0.0017871856689453125
▁to 0.31982421875
▁almost 5.25
▁all 1.3671875
▁survey 9.734375
▁questions 0.8427734375
. 0.31884765625
▁Pat 4.3515625
ients 0.0086517333984375
▁who 1.189453125
▁took 1.48046875
▁only 5.53125
▁MM 0.9462890625
▁or 3.302734375
▁mixed 3.4296875
▁medic 2.65625
ations 0.37939453125
▁course 12.5
▁had 2.46484375
▁a 1.28515625
▁significantly 2.67578125
▁more 4.15234375
▁stable 3.42578125
▁emot 1.5048828125
ional 0.01258087158203125
▁state 0.75830078125
▁and 1.3974609375
▁cop 5.62890625
ed 0.900390625
▁with 0.72119140625
▁pain 1.443359375
▁more 1.72265625
▁manage 6.94140625
able 2.28125
. 0.5458984375
<0x0A> 0.65673828125
One 5.1796875
▁of 0.6787109375
▁the 0.023223876953125
▁major 2.5390625
▁limitations 2.962890625
▁is 3.8203125
▁the 0.58935546875
▁ins 4.59765625
u 0.02056884765625
fficient 0.151611328125
ly 4.65625
▁high 2.9765625
▁response 2.99609375
▁rate 0.1351318359375
, 2.615234375
▁ 4.50390625
5 1.9169921875
7 2.044921875
% 2.125
▁instead 7.1328125
▁of 0.006748199462890625
▁ 0.703125
7 1.4990234375
0 1.466796875
% 1.1005859375
▁( 1.6552734375
Fe 0.2412109375
ing 0.0037097930908203125
old 0.0005040168762207031
▁et 0.006633758544921875
▁al 0.0005707740783691406
., 0.004734039306640625
▁ 0.001373291015625
2 0.00042438507080078125
0 2.467632293701172e-05
1 0.000888824462890625
7 0.006595611572265625
). 0.035919189453125
▁It 2.673828125
▁can 3.353515625
▁be 0.3955078125
▁fairly 8.203125
▁explained 1.5654296875
▁by 0.193115234375
▁the 0.356201171875
▁weak 8.0625
▁focus 7.234375
▁of 0.4619140625
▁respond 6.23046875
ents 0.1378173828125
▁who 3.4765625
▁have 3.947265625
▁overcome 8.09375
▁severe 2.275390625
▁pain 0.4931640625
▁sens 8.7109375
ations 1.134765625
▁and 1.2421875
▁de 4.1953125
press 1.728515625
ive 0.283447265625
▁episodes 4.08984375
. 0.6005859375
▁information 16.328125
_ 8.40625
techn 2.205078125
ology 0.0292816162109375
▁is 4.0
▁not 2.521484375
▁clear 8.6796875
▁how 4.28125
▁to 1.7412109375
▁use 4.046875
▁these 4.625
▁statistics 3.3046875
, 2.326171875
▁as 1.7392578125
▁they 1.595703125
▁still 6.28515625
▁may 5.57421875
▁be 1.236328125
▁relevant 6.24609375
▁for 1.4521484375
▁the 1.9423828125
▁overall 5.01953125
▁analysis 2.89453125
. 1.14453125
